Having shown that the stroma-derived antigen vimentin is displayed on the surface of viable stromal cells, we asked whether this BCR-antigen interaction can protect CLL 014 cells from apoptosis. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.